NASDAQ:ARGX

Argenx Se Stock Predictions

Healthcare > Biotechnology

Buy ARGX

*Your capital is at risk

$813.14

+10.97 (+1.37%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ARGX Prediction Chart

ARGX Predictions History

Latest community submissions for ARGX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 2, 2019	$122.03 -0.91%	$123.15	X	99.09%	1
NameNotImportant Pro	Apr 29, 2019	$125.84 -0.69%	$126.71	X	99.31%	3

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ARGX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ARGENX SE

argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy in Phase III clinical trials; bullous pemphigoid ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by